Predictive signature of murine and human host response to typical and atypical pneumonia.


Journal

BMJ open respiratory research
ISSN: 2052-4439
Titre abrégé: BMJ Open Respir Res
Pays: England
ID NLM: 101638061

Informations de publication

Date de publication:
03 Aug 2024
Historique:
received: 06 08 2023
accepted: 08 07 2024
medline: 4 8 2024
pubmed: 4 8 2024
entrez: 3 8 2024
Statut: epublish

Résumé

Pneumonia due to typical bacterial, atypical bacterial and viral pathogens can be difficult to clinically differentiate. Host response-based diagnostics are emerging as a complementary diagnostic strategy to pathogen detection. We used murine models of typical bacterial, atypical bacterial and viral pneumonia to develop diagnostic signatures and understand the host's response to these types of infections. Mice were intranasally inoculated with Mice infected with This study identified discrete host responses to typical bacterial, atypical bacterial and viral aetiologies of pneumonia in mice. These signatures validated well in humans, highlighting the conserved nature of the host response to these pathogen classes.

Sections du résumé

BACKGROUND BACKGROUND
Pneumonia due to typical bacterial, atypical bacterial and viral pathogens can be difficult to clinically differentiate. Host response-based diagnostics are emerging as a complementary diagnostic strategy to pathogen detection.
METHODS METHODS
We used murine models of typical bacterial, atypical bacterial and viral pneumonia to develop diagnostic signatures and understand the host's response to these types of infections. Mice were intranasally inoculated with
RESULTS RESULTS
Mice infected with
DISCUSSION CONCLUSIONS
This study identified discrete host responses to typical bacterial, atypical bacterial and viral aetiologies of pneumonia in mice. These signatures validated well in humans, highlighting the conserved nature of the host response to these pathogen classes.

Identifiants

pubmed: 39097412
pii: 11/1/e002001
doi: 10.1136/bmjresp-2023-002001
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Matthew McCravy (M)

Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA matthew.mccravy@duke.edu.

Nicholas O'Grady (N)

Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.

Kirin Khan (K)

Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.

Marisol Betancourt-Quiroz (M)

Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.

Aimee K Zaas (AK)

Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.

Amy E Treece (AE)

Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.

Zhonghui Yang (Z)

Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.

Loretta Que (L)

Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.

Ricardo Henao (R)

Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina, USA.

Sunil Suchindran (S)

Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.

Geoffrey S Ginsburg (GS)

Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.

Christopher W Woods (CW)

Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.

Micah T McClain (MT)

Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.

Ephraim L Tsalik (EL)

Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH